Selegiline Transdermal System: In the Treatment of Major Depressive DisorderA Viewpoint by J. Alexander Bodkin

被引：0

作者：

J. Alexander Bodkin

机构：

[1] Harvard Medical School,Consolidated Department of Psychiatry

来源：

Drugs | 2007年 / 67卷 / 2期

关键词：

D O I：

10.2165/00003495-200767020-00007

中图分类号：

学科分类号：

摘要：

引用

页码：266 / 266

共 50 条

[11] Selegiline transdermal patch (Emsam) for major depressive disorder
Melton, Sarah
Townsend, Charlotte Ann
AMERICAN FAMILY PHYSICIAN, 2008, 77 (04) : 505 - 506
[12] The selegiline transdermal system in major depressive disorder: A systematic review of safety and tolerability
Robinson, Donald S.
Amsterdam, Jay D.
JOURNAL OF AFFECTIVE DISORDERS, 2008, 105 (1-3) : 15 - 23
[13] A case report of high-dose transdermal selegiline in the treatment of major depressive disorder
Ashton, Adam Keller
ANNALS OF CLINICAL PSYCHIATRY, 2009, 21 (01) : 51 - 52
[14] Selegiline transdermal system for the treatment of major depressive disorder: A symptom-based analysis of placebo controlled efficacy trials
Robinson, Donald
Gilmor, Michelle
Eudicone, James
Moonsammy, George
Azzaro, Albert
Oren, Daniel
Campbell, Bryan
NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S108 - S108
[15] Safety and tolerability of the selegiline transdermal system 20 mg for treatment of major depression
Robinson, DS
Campbell, BJ
Amsterdam, JD
NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S234 - S234
[16] A Critical Appraisal of the Selegiline Transdermal System for Major Depressive Disorder (vol 8, pg 673, 2015)
Bied, A. M.
Kim, J.
Schwartz, Thomas L.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 339 - 339
[17] Selegiline transdermal system for major depressive disorder: use pattern, adherence, and effect on health service expenditures
Sclar, D. A.
Cohen, L. J.
Portland, K.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S256 - S256
[18] Efficacy of selegiline transdermal system for major depressive disorder as measured by the HAM-D 6-item Bech subscale
Sambunaris, Angelo
Campbell, Bryan
Azzaro, Albert
Moonsammy, George
Robinson, Donald
NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S94 - S94
[19] Efficacy of selegiline transdermal system for major depressive disorder as measured by the HAM-D 6-item Bech subscale
Robinson, D. S.
Azzar, A. J.
Moonsammy, G. I.
Campbell, B.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S260 - S261
[20] Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
Robinson, Donald S.
Gilmor, Michelle L.
Yang, Ying
Moonsammy, George
Azzaro, Albert J.
Oren, Dan A.
Campbell, Bryan J.
PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (03) : 15 - 28

← 1 2 3 4 5 →